Genetic reprogramming of rHemnant duodenum may contribute to type 2 diabetes improvement after Roux-en-Y gastric bypass (2022)
- Authors:
- Sala, Priscila
- Machado, Natasha Mendonca
- Torrinhas, Raquel Susana Matos de Miranda
- Fonseca, Danielle C.
- Ferreira, Beatriz A. M.
- Ishida, Robson Kiyoshi
- Guarda, Ismael Francisco Mota Siqueira
- Moura, Eduardo Guimaraes Hourneaux de
- Sakai, Paulo
- Santo, Marco Aurelio
- Giannella, Maria Lucia Cardillo Correa
- Waitzberg, Dan Linetzky
- USP affiliated authors: TORRINHAS, RAQUEL SUSANA MATOS DE MIRANDA - FM ; SAKAI, PAULO - FM ; SANTO, MARCO AURELIO - FM ; GIANNELLA, MARIA LUCIA CARDILLO CORREA - FM ; WAITZBERG, DAN LINETZKY - FM
- Unidade: FM
- DOI: 10.1016/j.nut.2022.111631
- Subjects: OBESIDADE; DIABETES MELLITUS; DUODENO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SALA, Priscila et al. Genetic reprogramming of rHemnant duodenum may contribute to type 2 diabetes improvement after Roux-en-Y gastric bypass. Nutrition, v. 99-100, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.nut.2022.111631. Acesso em: 28 dez. 2025. -
APA
Sala, P., Machado, N. M., Torrinhas, R. S. M. de M., Fonseca, D. C., Ferreira, B. A. M., Ishida, R. K., et al. (2022). Genetic reprogramming of rHemnant duodenum may contribute to type 2 diabetes improvement after Roux-en-Y gastric bypass. Nutrition, 99-100. doi:10.1016/j.nut.2022.111631 -
NLM
Sala P, Machado NM, Torrinhas RSM de M, Fonseca DC, Ferreira BAM, Ishida RK, Guarda IFMS, Moura EGH de, Sakai P, Santo MA, Giannella MLCC, Waitzberg DL. Genetic reprogramming of rHemnant duodenum may contribute to type 2 diabetes improvement after Roux-en-Y gastric bypass [Internet]. Nutrition. 2022 ; 99-100[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.nut.2022.111631 -
Vancouver
Sala P, Machado NM, Torrinhas RSM de M, Fonseca DC, Ferreira BAM, Ishida RK, Guarda IFMS, Moura EGH de, Sakai P, Santo MA, Giannella MLCC, Waitzberg DL. Genetic reprogramming of rHemnant duodenum may contribute to type 2 diabetes improvement after Roux-en-Y gastric bypass [Internet]. Nutrition. 2022 ; 99-100[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.nut.2022.111631 - Gastrointestinal genetic reprogramming of vitamin A metabolic pathways in response of Roux-en-Y gastric bypass
- Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass
- Intestinal expression of toll-like receptor gene changes early after gastric bypass surgery and association with type 2 diabetes remission
- Gastrointestinal Transcriptomic Response of Metabolic Vitamin B12 Pathways in Roux-en-Y Gastric Bypass
- Type 2 diabetes metabolic improvement after roux-en-Y gastric bypass may include a compensatory mechanism that balances fatty acid beta and omega oxidation
- Cholecystectomy - a potential selection bias in studies assessing the metabolic effects of bariatric surgeries
- The SURMetaGIT study: design and rationale for a prospective pan-omics examination of the gastrointestinal response to Roux-en-Y gastric bypass surgery
- Partial Replacement of ω-6 Fatty Acids With Medium-Chain Triglycerides, but Not Olive Oil, Improves Colon Cytokine Response and Damage in Experimental Colitis
- Upregulation of Ghrelin Gene Expression in the Excluded Stomach of Obese Women with Type 2 Diabetes After Roux-en-Y Gastric Bypass in the SURMetaGIT Study
- A new anthropometric index for body fat estimation in patients with severe obesity
Informações sobre o DOI: 10.1016/j.nut.2022.111631 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
